EDN1 and pulmonary arterial hypertension: PVECs from PAH patients exhibit increased production of growth factors, such as FGF2, IL-6, ET-1, TGF-beta, etc. These factors promote PVECs/smooth muscle cells (SMCs)/fibroblast proliferation and survival, stimulate SMC vasoconstriction, and even recruit leukocytes [6].